Suppr超能文献

医生对开具纳洛酮以逆转意外阿片类药物过量的了解及意愿:挑战与机遇

Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

作者信息

Beletsky Leo, Ruthazer Robin, Macalino Grace E, Rich Josiah D, Tan Litjen, Burris Scott

机构信息

Temple University Beasley School of Law, Philadelphia, PA 19122, USA.

出版信息

J Urban Health. 2007 Jan;84(1):126-36. doi: 10.1007/s11524-006-9120-z.

Abstract

Naloxone, the standard treatment for heroin overdose, is a safe and effective prescription drug commonly administered by emergency room physicians or first responders acting under standing orders of physicians. High rates of overdose deaths and widely accepted evidence that witnesses of heroin overdose are often unwilling or unable to call 9-1-1 has led to interventions in several US cities and abroad in which drug users are instructed in overdose rescue techniques and provided a "take-home" dose of naloxone. Under current Food and Drug Administration (FDA) regulations, such interventions require physician involvement. As part of a larger study to evaluate the knowledge and attitudes of doctors towards providing drug treatment and harm reduction services to injection drug users (IDUs), we investigated physician knowledge and willingness to prescribe naloxone. Less than one in four of the respondents in our sample reported having heard of naloxone prescription as an intervention to prevent opiate overdose, and the majority reported that they would never consider prescribing the agent and explaining its application to a patient. Factors predicting a favorable attitude towards prescribing naloxone included fewer negative perceptions of IDUs, assigning less importance to peer and community pressure not to treat IDUs, and increased confidence in ability to provide meaningful treatment to IDUs. Our data suggest that steps to promote naloxone distribution programs should include physician education about evidence-based harm minimization schemes, broader support for such initiatives by professional organizations, and policy reform to alleviate medicolegal concerns associated with naloxone prescription. FDA re-classification of naloxone for over-the-counter sales and promotion of nasal-delivery mechanism for this agent should be explored.

摘要

纳洛酮是治疗海洛因过量的标准药物,是一种安全有效的处方药,通常由急诊室医生或根据医生长期医嘱行事的急救人员给药。海洛因过量致死率居高不下,且有广泛认可的证据表明,海洛因过量的目击者往往不愿或无法拨打911,这促使美国和其他国家的几个城市采取干预措施,指导吸毒者掌握过量急救技术,并提供一剂“可带回家的”纳洛酮。根据美国食品药品监督管理局(FDA)目前的规定,此类干预措施需要医生参与。作为一项更大规模研究的一部分,该研究旨在评估医生对为注射吸毒者(IDU)提供药物治疗和减少伤害服务的知识和态度,我们调查了医生对开具纳洛酮处方的知识和意愿。在我们样本中的受访者中,不到四分之一的人表示听说过将纳洛酮处方作为预防阿片类药物过量的一种干预措施,大多数人表示他们永远不会考虑为患者开具这种药物并解释其用法。预测对开具纳洛酮持积极态度的因素包括对注射吸毒者的负面看法较少、不太重视来自同行和社区不治疗注射吸毒者的压力,以及对为注射吸毒者提供有效治疗的能力更有信心。我们的数据表明,促进纳洛酮分发项目的措施应包括对医生进行基于证据的伤害最小化方案的教育、专业组织对此类举措提供更广泛的支持,以及进行政策改革以减轻与纳洛酮处方相关的法医学担忧。应探索FDA将纳洛酮重新分类为非处方药销售以及推广该药物的鼻腔给药机制。

相似文献

4
Evaluation of a naloxone distribution and administration program in New York City.
Subst Use Misuse. 2008;43(7):858-70. doi: 10.1080/10826080701801261.
6
Opioid education and nasal naloxone rescue kits in the emergency department.
West J Emerg Med. 2015 May;16(3):381-4. doi: 10.5811/westjem.2015.2.24909. Epub 2015 Apr 1.
7
Opioid overdose prevention with intranasal naloxone among people who take methadone.
J Subst Abuse Treat. 2013 Feb;44(2):241-7. doi: 10.1016/j.jsat.2012.07.004. Epub 2012 Sep 12.
8
Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
BMJ Case Rep. 2015 Sep 14;2015:bcr2015210391. doi: 10.1136/bcr-2015-210391.
9
A qualitative evaluation of a peer-implemented overdose response pilot project in Gejiu, China.
Int J Drug Policy. 2011 Jul;22(4):301-5. doi: 10.1016/j.drugpo.2011.04.005. Epub 2011 Jun 11.

引用本文的文献

2
Bridging the Gap Between Knowledge and Practices Pertaining to Naloxone Use: A Single-Institution Experience in North Carolina.
J Patient Cent Res Rev. 2025 Apr 22;12(2):76-81. doi: 10.17294/2330-0698.2103. eCollection 2025 Spring.
3
Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients.
J Health Econ. 2024 Sep;97:102917. doi: 10.1016/j.jhealeco.2024.102917. Epub 2024 Jul 17.
4
Physician Reluctance to Intervene in Addiction: A Systematic Review.
JAMA Netw Open. 2024 Jul 1;7(7):e2420837. doi: 10.1001/jamanetworkopen.2024.20837.
5
Machine Learned Classification of Ligand Intrinsic Activities at Human μ-Opioid Receptor.
ACS Chem Neurosci. 2024 Aug 7;15(15):2842-2852. doi: 10.1021/acschemneuro.4c00212. Epub 2024 Jul 11.
6
Machine Learned Classification of Ligand Intrinsic Activities at Human -Opioid Receptor.
bioRxiv. 2024 Jun 14:2024.04.07.588485. doi: 10.1101/2024.04.07.588485.
7
Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
JAMA Netw Open. 2023 Aug 1;6(8):e2327319. doi: 10.1001/jamanetworkopen.2023.27319.
8
Assessment of Oncology Advanced Practice Professional Willingness to Participate in Medical Aid in Dying.
JAMA Netw Open. 2022 Oct 3;5(10):e2239068. doi: 10.1001/jamanetworkopen.2022.39068.
10
Intention to get naloxone among patients prescribed opioids for chronic pain.
Harm Reduct J. 2022 Sep 22;19(1):104. doi: 10.1186/s12954-022-00687-5.

本文引用的文献

2
Attitudes of Emergency Medical Service providers towards naloxone distribution programs.
J Urban Health. 2005 Jun;82(2):296-302. doi: 10.1093/jurban/jti052. Epub 2005 May 25.
4
Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users.
Arch Intern Med. 2005 Mar 28;165(6):618-23. doi: 10.1001/archinte.165.6.618.
5
Physician substance abuse and recovery: what does it mean for physicians--and everyone else?
JAMA. 2005 Mar 23;293(12):1513-5. doi: 10.1001/jama.293.12.1513.
10
Heroin overdose: research and evidence-based intervention.
J Urban Health. 2003 Jun;80(2):189-200. doi: 10.1093/jurban/jtg022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验